Difference between revisions of "van der Zee M, et al. Cancer Res. (2015) cited as Ref 320 in DOI: 10.1038/s41392-020-0110-5 (Q9583)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 75, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): IL6/JAK1/STAT3 signaling blockade in endometrial cancer affects the ALDHhi/CD126+ stem-like component and reduces tumor burden, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | IL6/JAK1/STAT3 signaling blockade in endometrial cancer affects the ALDHhi/CD126+ stem-like component and reduces tumor burden (English) | ||
| Property / title: IL6/JAK1/STAT3 signaling blockade in endometrial cancer affects the ALDHhi/CD126+ stem-like component and reduces tumor burden (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:58, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
van der Zee M, et al. Cancer Res. (2015) cited as Ref 320 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
van der Zee M
0 references
2015
0 references
Cancer Res.
0 references
75
0 references
IL6/JAK1/STAT3 signaling blockade in endometrial cancer affects the ALDHhi/CD126+ stem-like component and reduces tumor burden (English)
0 references
